Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
Di-phenyl-di-(2,4-difluobenzohydroxamato)tin(IV)(DPDFT), a new metal-based arylhydroxamate antitumor complex, showed high in vivo and in vitro antitumor activity with relative low toxicity, but no data was reported regarding its pharmacokinetics and dependent toxicity. In this paper, a rapid, sensit...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2012/210682 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832546127433433088 |
---|---|
author | Yunlan Li Zhuyan Gao Pu Guo Qingshan Li |
author_facet | Yunlan Li Zhuyan Gao Pu Guo Qingshan Li |
author_sort | Yunlan Li |
collection | DOAJ |
description | Di-phenyl-di-(2,4-difluobenzohydroxamato)tin(IV)(DPDFT), a new metal-based arylhydroxamate antitumor complex, showed high in vivo and in vitro antitumor activity with relative low toxicity, but no data was reported regarding its pharmacokinetics and dependent toxicity. In this paper, a rapid, sensitive, and reproducible HPLC method in vivo using Diamonsil ODS column with a mixture of methanol and phosphoric acid in water (30 : 70, V/V, pH 3.0) as mobile phase was developed and validated for the determination of DPDFT. The plasma was deproteinized with methanol that contained acetanilide as the internal standard (I.S.). The photodiode array detector was set at a wavelength of 228 nm at room temperature and a linear curve over the concentration range 0.1~25 μg·mL-1 (r = 0.9993) was obtained. The method was used to determine the concentration-time profiles for DPDFT in the plasma after single intravenous administration with doses of 5, 10, 15 mg·kg-1 to rats. The pharmacokinetics parameter calculations and modeling were carried out using the 3p97 software. The results showed that the concentration-time curves of DPDFT in rat plasma could be fitted to two-compartment model. |
format | Article |
id | doaj-art-49ff964c14d94171adb994c7b04feb69 |
institution | Kabale University |
issn | 1565-3633 1687-479X |
language | English |
publishDate | 2012-01-01 |
publisher | Wiley |
record_format | Article |
series | Bioinorganic Chemistry and Applications |
spelling | doaj-art-49ff964c14d94171adb994c7b04feb692025-02-03T07:23:50ZengWileyBioinorganic Chemistry and Applications1565-36331687-479X2012-01-01201210.1155/2012/210682210682Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor PotentialYunlan Li0Zhuyan Gao1Pu Guo2Qingshan Li3School of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaSchool of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaSchool of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaSchool of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, ChinaDi-phenyl-di-(2,4-difluobenzohydroxamato)tin(IV)(DPDFT), a new metal-based arylhydroxamate antitumor complex, showed high in vivo and in vitro antitumor activity with relative low toxicity, but no data was reported regarding its pharmacokinetics and dependent toxicity. In this paper, a rapid, sensitive, and reproducible HPLC method in vivo using Diamonsil ODS column with a mixture of methanol and phosphoric acid in water (30 : 70, V/V, pH 3.0) as mobile phase was developed and validated for the determination of DPDFT. The plasma was deproteinized with methanol that contained acetanilide as the internal standard (I.S.). The photodiode array detector was set at a wavelength of 228 nm at room temperature and a linear curve over the concentration range 0.1~25 μg·mL-1 (r = 0.9993) was obtained. The method was used to determine the concentration-time profiles for DPDFT in the plasma after single intravenous administration with doses of 5, 10, 15 mg·kg-1 to rats. The pharmacokinetics parameter calculations and modeling were carried out using the 3p97 software. The results showed that the concentration-time curves of DPDFT in rat plasma could be fitted to two-compartment model.http://dx.doi.org/10.1155/2012/210682 |
spellingShingle | Yunlan Li Zhuyan Gao Pu Guo Qingshan Li Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential Bioinorganic Chemistry and Applications |
title | Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential |
title_full | Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential |
title_fullStr | Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential |
title_full_unstemmed | Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential |
title_short | Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential |
title_sort | pharmacokinetic study of di phenyl di 2 4 difluobenzohydroxamato tin iv novel metal based complex with promising antitumor potential |
url | http://dx.doi.org/10.1155/2012/210682 |
work_keys_str_mv | AT yunlanli pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential AT zhuyangao pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential AT puguo pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential AT qingshanli pharmacokineticstudyofdiphenyldi24difluobenzohydroxamatotinivnovelmetalbasedcomplexwithpromisingantitumorpotential |